Bristol-Myers Squibb Co. (BMY)

• Annual Data
• Quarterly Data

Bristol-Myers Squibb Co., Common-Size Consolidated Income Statement (quarterly data)

Based on: 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29), 10-K (filing date: 2014-02-14), 10-Q (filing date: 2013-10-23), 10-Q (filing date: 2013-07-25), 10-Q (filing date: 2013-04-25).

Item	Description	The company
Operating income	The net result for the period of deducting operating expenses from operating revenues.	Bristol-Myers Squibb Co.’s operating income as a percentage of revenues declined from Q1 2018 to Q2 2018 but then slightly increased from Q2 2018 to Q3 2018.
Earnings before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Bristol-Myers Squibb Co.’s earnings before income taxes as a percentage of revenues declined from Q1 2018 to Q2 2018 but then slightly increased from Q2 2018 to Q3 2018.
Net earnings (loss) attributable to BMS	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Bristol-Myers Squibb Co.’s net earnings (loss) attributable to BMS as a percentage of revenues declined from Q1 2018 to Q2 2018 but then slightly increased from Q2 2018 to Q3 2018.